CAMBRIDGE, MA --(Marketwired - September 29, 2016) - Elsevier , a world-leading provider of scientific, technical and medical information products and services, today announced that it has partnered with the International Society for Neurovascular Disease (ISNVD) to develop and publish an ISNVD-cobranded series of books covering various topics in neurovascular disease. The book series will focus on the latest research in diagnostic and therapeutic modalities for neurovascular disease and its underlying cellular and molecular mechanisms.
"We are thrilled to partner with the ISNVD on a book series that will bring top research in neurovascular disease to the global community," said Melanie Tucker, Senior Acquisitions Editor, Elsevier. "We look forward to a long and fruitful collaboration."
Elsevier and the ISNVD agreed to publish one-to-two books per year, including both edited volumes and monographs on specific topics in neurovascular disease. The co-branded books will range from 300 to 500 pages each, with 15 to 25 chapters. The final published books will be available in both print and electronic formats, and hosted on Elsevier's ScienceDirect .
"We are delighted to announce that the ISNVD has joined forces with Elsevier to produce a series of books on key topics, including those that were discussed in the ISNVD 2016 meeting in New York," noted J. Steve Alexander, President, ISNVD. "The books will cover various aspects of neurological diseases and beyond."
Note for editors E-book review copies of the new books will be available to credentialed journalists upon request. Contact Jelena Baras at sciencereviewcopies@elsevier.com .
About ISNVD The International Society for Neurovascular Disease is a non-profit professional association established in 2010. The ISNVD is dedicated to the dissemination and review of new concepts in etiopathogenesis, novel diagnostics and modes of therapeutic treatment in the diseases of the neurovasculature. One of their main goals is to promote communication, research, development, applications, publications and the availability of information on neurovascular and related neurodegenerative diseases such as multiple sclerosis internationally. Their Executive Committee is comprised of many of the leading researchers and clinicians in the field. The Society holds an annual scientific meeting and sponsors educational and scientific workshops. Members are mostly researchers and clinicians in neurology, neurosurgery, vascular surgery, and interventional radiology. https://isnvd.org
About Elsevier Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions -- among them ScienceDirect , Scopus , Research Intelligence and ClinicalKey -- and publishes over 2,500 journals, including The Lancet and Cell , and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group , a world-leading provider of information and analytics for professional and business customers across industries. www.elsevier.com
Media contact Pam Foote Publicity Team, Science & Technology Books, Elsevier +1 978 691 5572 footep@reedelsevier.com
